• About
    • Mission
    • Leadership
    • Careers
    • Clinical Advisory Board
    • News
    • Media & Press
    • Events
  • Viveve Solutions
    • Viveve System
    • InControl
  • Healthcare Providers
    • Clinical Studies
    • Become a Provider
    • Manage Your Listing
    • Hub Login
    • FAQs
    • Product Feedback
  • Patients
    • Blog
    • Find A Provider
    • Refer A Provider
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
    • FAQs
    • Viveve Hub
    • Submit a Product Experience
  • Product Indication
Select Page
Viveve | US

Press Releases

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Publications
    • IR Calendar
    • Analyst Coverage
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Clinical Advisory Board
    • Medical Consultants
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Investor Presentation
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • Publications
  • IR Calendar
  • Analyst Coverage
  • Email Alerts

Viveve(R) Expands in Latin America With Six New Distribution Partnerships

Jul 5, 2016

Viveve(R) Announces Closing of $10 Million Senior Secured Term Loan With Bridge Bank

Jun 20, 2016

Viveve(R) Announces Closing of $15.5 Million Underwritten Public Offering

Jun 17, 2016

Viveve(R) Announces Pricing of $13.5 Million Public Offering of Shares of Common Stock and NASDAQ Uplisting

Jun 14, 2016

Viveve(R) Announces Election of Three New Independent Board Directors

May 12, 2016

Viveve(R) Announces Positive Topline Results for VIVEVE I Clinical Trial

Apr 21, 2016

Viveve(R) Announces First Quarter Financial Highlights

Apr 19, 2016

Viveve(R) Issues Corrective Ticker Symbol Press Release

Apr 18, 2016

Viveve(R) Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ

Apr 14, 2016

Viveve(R) Reports Fourth Quarter and Full Year 2015 Financial Results

Mar 24, 2016
RSS
    • 1...
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • ...31

    Viveve

    A Global Women’s Intimate Health Company

    Terms of Use | Privacy Policy
    © 2021 Viveve Solutions. All Rights Reserved.

    • About
    • Viveve Solutions
    • Providers
    • Patients
    • Investors
    • Careers
    • Contact Us



    • Hub Login
    • Product Feedback

    345 Inverness Drive South
    Building B, Suite 250
    Englewood, CO 80112

    The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States.

    The Viveve® System is an internationally patented cryogen-cooled monopolar radiofrequency (CMRF) energy-based platform device. It has received regulatory approvals and clearances in many countries throughout the world and is available through physician import license in Japan and China. In the United States the Viveve System is cleared by the FDA for general surgery procedures for electrocoagulation and hemostasis. International approvals and clearances include vaginal laxity and/or improvement of sexual function indications. In Argentina improvement of urinary incontinence in women is also an approved indication.

    Translate »